 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 3653 | 回復(fù): 14 | |||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | |||
rongzai木蟲 (著名寫手)
|
[交流]
論文校樣都結(jié)束了，IN PRESS中，最后來了個(gè)這個(gè)，什么意思 已有13人參與
|
||
|
????У???????????IN PRESS?У??????????????????? Dear Dr Liu, Announcing the Final Programme for Pharma-Nutrition Conference Secure your place at the Pharma-Nutrition Conference, which will take place on 18-20 April at Amsterdam's NH Grand Hotel Krasnapolsky. The state of the art programme is now available online at http://www.pharma-nutrition.com/programme.asp. This programme is dedicated to bringing the two communities together and gaining further insights into many new therapeutic research areas. This includes seeing how the pharmacologists, clinicians and nutritional scientists are working towards practical applications of medical nutrition in improving patient treatments, disease management and patient outcomes. There will also be a chance for young investigators to showcase their research with the Young Investigator Award Ceremony. An author workshop will also provide a valuable insight in to the publishing world. Young Investigator Award Ceremony Ten outstanding submissions will be nominated for the award which is designed to acknowledge research contributions that further the development and knowledge on the interface between nutrition and pharma. The ten selected abstracts will be judged during the first two days of the conference. The judging criteria being: Originality of research concept Soundness of research design Quality/clarity of research report Perceived value of the research to Pharma-Nutrition Three final nominees will then be selected to present a 5 minute oral presentation during the opening session on Day 3. One outstanding young investigator will be selected as the recipient of the award, and will receive a certificate and a ?500 cash prize. Author Workshop Spanning 2 and half days the conference will include sessions on Oncology, Infectious Diseases, COPD/Asthma, and Allergy. At the end of the conference there will be a complimentary post-conference author workshop. Dr. Jaap van Harten, executive publisher at Elsevier, explains why such a workshop will be held; "we hope that this workshop will provide a valuable opportunity for the direct interaction between authors, editors and publishers. Providing answers to questions such as what is a well-written manuscript , what are the do's and don'ts of manuscript writing (including publication ethics), how do editors come to their decisions, and what happens behind the scenes from manuscript submission to publication." .... Kind regards, Jaap van Harten Elsevier Executive Publisher Pharmacology & Pharmaceutical Sciences ????????????????ù?????????????????????λ??????лл?????????????????? |
回復(fù)此樓» 猜你喜歡
293求調(diào)劑
已經(jīng)有14人回復(fù)
-
0703化學(xué)336分求調(diào)劑
已經(jīng)有6人回復(fù)
-
304求調(diào)劑
已經(jīng)有9人回復(fù)
-
281求調(diào)劑（0805）
已經(jīng)有8人回復(fù)
-
環(huán)境領(lǐng)域全國重點(diǎn)實(shí)驗(yàn)室招收博士1-2名
已經(jīng)有3人回復(fù)
-
材料專碩306英一數(shù)二
已經(jīng)有10人回復(fù)
-
301求調(diào)劑
已經(jīng)有6人回復(fù)
-
一志愿天津大學(xué)化學(xué)工藝專業(yè)（081702）315分求調(diào)劑
已經(jīng)有7人回復(fù)
-
302求調(diào)劑
已經(jīng)有6人回復(fù)
-
26博士申請(qǐng)
已經(jīng)有3人回復(fù)
» 本主題相關(guān)價(jià)值貼推薦，對(duì)您同樣有幫助:
- 大家?guī)涂纯催@段話什么意思
已經(jīng)有3人回復(fù)
- 期刊狀態(tài)光是已采用
已經(jīng)有6人回復(fù)
- 求助關(guān)于投稿問題
已經(jīng)有8人回復(fù)
- 一篇文章已接收，想從不同的側(cè)面寫該內(nèi)容能否再投呢
已經(jīng)有10人回復(fù)
- 酶解多少g底物對(duì)應(yīng)多少酶活力是什么意思？
已經(jīng)有9人回復(fù)
- 同一篇論文今年申報(bào)省里的軟科學(xué)獎(jiǎng)，明年還能申報(bào)教育部獎(jiǎng)嗎？
已經(jīng)有3人回復(fù)
- 在藥物化學(xué)中 PK profile 怎么翻譯 是什么意思啊
已經(jīng)有11人回復(fù)
- International Journal for Numerical Methods in Engineering二審時(shí)間
已經(jīng)有13人回復(fù)
- 論文翻譯，，急用，，求高手��！
已經(jīng)有1人回復(fù)
- Provide certificate 什么意思
已經(jīng)有23人回復(fù)
- 小老板要做最后一個(gè)作者和通訊作者，真苦惱�。�
已經(jīng)有22人回復(fù)
- a revision has been started 什么意思啊，不是已經(jīng)遞交了吧？
已經(jīng)有7人回復(fù)
- 參考文獻(xiàn)后面的“in press”什么意思�。�？
已經(jīng)有9人回復(fù)
- 求《印染》雜志投稿策略
已經(jīng)有10人回復(fù)
- 二審都結(jié)束了，又加了個(gè)審稿人，來了次重新審稿，提了34條意見！好難受
已經(jīng)有59人回復(fù)
- 校樣時(shí)文章中紅框是什么意思？
已經(jīng)有7人回復(fù)
- 求助“校樣"時(shí)"AUTHOR QUERY FORM"中一句話的意思
已經(jīng)有6人回復(fù)
jwdxbjzh
至尊木蟲 (職業(yè)作家)
- 應(yīng)助: 8 (幼兒園)
- 貴賓: 0.015
- 金幣: 10699.3
- 散金: 437
- 紅花: 30
- 帖子: 3868
- 在線: 1074.8小時(shí)
- 蟲號(hào): 611748
- 注冊(cè): 2008-09-25
- 性別: GG
- 專業(yè): 生物無機(jī)化學(xué)
7樓2011-02-12 11:58:26
rongzai
木蟲 (著名寫手)
- 應(yīng)助: 13 (小學(xué)生)
- 金幣: 2757.6
- 散金: 175
- 紅花: 5
- 帖子: 2214
- 在線: 335.8小時(shí)
- 蟲號(hào): 131865
- 注冊(cè): 2005-12-12
- 性別: GG
- 專業(yè): 有機(jī)合成
2樓2011-02-12 10:45:30
3樓2011-02-12 10:47:00
wishle
銀蟲 (小有名氣)
- 應(yīng)助: 3 (幼兒園)
- 金幣: 526.5
- 帖子: 105
- 在線: 41.8小時(shí)
- 蟲號(hào): 384513
- 注冊(cè): 2007-05-27
- 性別: GG
- 專業(yè): 有機(jī)合成
5樓2011-02-12 11:33:58
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 296求調(diào)劑 +5 | 大口吃飯 身體健 2026-03-13 | 5/250 |
|
|---|---|---|---|---|
|
[考研] 268求調(diào)劑 +7 | 好運(yùn)連綿不絕 2026-03-12 | 8/400 |
|
|
|
[考研] 308求調(diào)劑 +4 | 是Lupa啊 2026-03-16 | 4/200 |
|
|
|
[考研] 工科材料085601 279求調(diào)劑 +3 | 困于星晨 2026-03-17 | 3/150 |
|
|
|
[考研] 267一志愿南京工業(yè)大學(xué)0817化工求調(diào)劑 +6 | SUICHILD 2026-03-12 | 6/300 |
|
|
|
[考研] 化學(xué)調(diào)劑0703 +8 | 啊我我的 2026-03-11 | 8/400 |
|
|
|
[基金申請(qǐng)]
今年的國基金是打分制嗎？
 50+3
|
zhanghaozhu 2026-03-14 | 3/150 |
|
|
|
[考研] 0703化學(xué)調(diào)劑，求各位老師收留 +8 | 秋有木北 2026-03-14 | 8/400 |
|
|
|
[考研] 0703化學(xué)調(diào)劑 290分有科研經(jīng)歷，論文在投 +7 | 膩膩gk 2026-03-14 | 7/350 |
|
|
|
[教師之家] 焦慮 +7 | 水冰月月野兔 2026-03-13 | 9/450 |
|
|
|
[考研] 材料工程327求調(diào)劑 +3 | xiaohe12w 2026-03-11 | 3/150 |
|
|
|
[基金申請(qǐng)] 現(xiàn)在如何回避去年的某一個(gè)專家，不知道名字 +3 | zk200107 2026-03-12 | 6/300 |
|
|
|
[考研] 255求調(diào)劑 +3 | 李嘉慧， 2026-03-12 | 4/200 |
|
|
|
[考研] 復(fù)試調(diào)劑 +3 | 呼呼？~+123456 2026-03-14 | 3/150 |
|
|
|
[考研] 266求調(diào)劑 +4 | 學(xué)員97LZgn 2026-03-13 | 4/200 |
|
|
|
[考研] 材料與化工（0856）304求B區(qū)調(diào)劑 +6 | 邱gl 2026-03-12 | 7/350 |
|
|
|
[考研] 304求調(diào)劑 +6 | Mochaaaa 2026-03-12 | 7/350 |
|
|
|
[考研] 工科，求調(diào)劑 +3 | 我887 2026-03-11 | 3/150 |
|
|
|
[考研] 321求調(diào)劑（食品/專碩） +3 | xc321 2026-03-12 | 6/300 |
|
|
|
[考研] 333求調(diào)劑 +3 | 152697 2026-03-12 | 4/200 |
|